ST
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.044
Exchange
XLON - London Stock Exchange
0.047 B
Last period Assets ,GBP
12%
Assets has increased in 5 years
What is Assets ?
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
See also Shield Therapeutics
Company Analysis
STX.L valuation, rating, competitors, insights and company profile
Eyestock Rating
STX.L financial analysis by Eyestock methodology
Valuation
STX.L valuation using historical relative method
Statements
STX.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
STX.L dividend yield and annual dividend
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
Shield Therapeutics`s Assets for the period ended 2024-06-30 are 0.047 B GBP
